Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Diabetes
•
Endocrinology
Do you recommend up-titrating the Metformin dose of patients with T2DM who are at goal A1c in order to decrease their risk of diabetes-related delirium?
https://doi.org/10.2337/dc24-1414
Related Questions
Do you recommend the use of Korlym (Mifepristone) for patients with difficult to control diabetes and evidence of mild endogenous hypercortisolism of unknown source?
Does oral semaglutide provide similar cardiovascular risk reduction benefits as injectable semaglutide?
Is Metformin contraindicated in patients using long term oxygen therapy at home?
Are recurrent UTIs a contraindication to SGLT2i use?
Do you recommend continuous glucose monitoring for patients with Type 2 diabetes who are not on insulin?
Do you recommend Alpha Lipoic Acid to patients with diabetic polyneuropathy?
Is there a role for using continuous glucose monitors for perioperative glucose monitoring in patients with diabetes?
When do you recommend screening patients with T2DM for heart failure?
Does your decision to start or continue Ozempic therapy in patients with diabetic retinopathy depend on the severity of the retinopathy?
How many days prior to surgery do you recommend stopping SGLT2 inhibitors and when is it safe to resume therapy?
